• Horizon Pharma Business Development

Business Development Overview

Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. We are focused on executing on our aggressive business development strategy via product/company acquisitions and strategic alliances to maximize shareholder value creation.

Business Development Priorities

  • U.S. marketed products to leverage our core commercial strengths in primary care, rheumatology and orphan disease markets
  • Products with differentiated clinical benefits
  • Differentiated and/or underappreciated assets with a targeted commercial approach, regardless of therapeutic area
  • Long-life assets

We will also evaluate opportunities outside our core priorities if they may provide attractive financial returns for our shareholders.

Horizon Pharma Partners

AstraZeneca
Grunethal

MundiPharma
Aralez

Skyepharma

If you would like to submit business development opportunities to Horizon Pharma, please contact us at bd@horizonpharma.com.

Powered by WordPress. Designed by Woo Themes